Armada Acquisition Corp. III M&A Deal with Brains Bioceutical Corp.
Armada Acquisition Corp. III (SPAC) entered into a definitive business combination agreement with Brains Bioceutical Corp., a life sciences company specializing in pharmaceutical API manufacturing and drug development. The transaction values Brains at an implied pre-money equity value of $750 million and will result in the combined company, Brains Therapeutics Corp., listing on the Nasdaq under the ticker symbol 'BAPI'.
- Counterparty
- Brains Bioceutical Corp.